mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.0002 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0006 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0007 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0007 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |